BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10867641)

  • 1. The mitogenic activity of fibroblast growth factor-1 correlates with its internalization and limited proteolytic processing.
    Grieb TA; Burgess WH
    J Cell Physiol; 2000 Aug; 184(2):171-82. PubMed ID: 10867641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
    Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
    J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of FGF-2 binding to heparan sulfate proteoglycans and MAP kinase signaling.
    Forsten-Williams K; Chua CC; Nugent MA
    J Theor Biol; 2005 Apr; 233(4):483-99. PubMed ID: 15748910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-2 induces osteoblast survival through a phosphatidylinositol 3-kinase-dependent, -beta-catenin-independent signaling pathway.
    Debiais F; Lefèvre G; Lemonnier J; Le Mée S; Lasmoles F; Mascarelli F; Marie PJ
    Exp Cell Res; 2004 Jul; 297(1):235-46. PubMed ID: 15194439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action.
    Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J
    J Mol Biol; 2005 Sep; 352(4):860-75. PubMed ID: 16126225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional diversity of FGF-2 isoforms by intracellular sorting.
    Sørensen V; Nilsen T; Wiedłocha A
    Bioessays; 2006 May; 28(5):504-14. PubMed ID: 16615083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2.
    Chua CC; Rahimi N; Forsten-Williams K; Nugent MA
    Circ Res; 2004 Feb; 94(3):316-23. PubMed ID: 14684627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential.
    Fakhry A; Ratisoontorn C; Vedhachalam C; Salhab I; Koyama E; Leboy P; Pacifici M; Kirschner RE; Nah HD
    Bone; 2005 Feb; 36(2):254-66. PubMed ID: 15780951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural requirements of FGF-1 for receptor binding and translocation into cells.
    Zakrzewska M; Krowarsch D; Wiedlocha A; Olsnes S; Otlewski J
    Biochemistry; 2006 Dec; 45(51):15338-48. PubMed ID: 17176056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translokin is an intracellular mediator of FGF-2 trafficking.
    Bossard C; Laurell H; Van den Berghe L; Meunier S; Zanibellato C; Prats H
    Nat Cell Biol; 2003 May; 5(5):433-9. PubMed ID: 12717444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor.
    Francavilla C; Loeffler S; Piccini D; Kren A; Christofori G; Cavallaro U
    J Cell Sci; 2007 Dec; 120(Pt 24):4388-94. PubMed ID: 18042627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activation of the cell proliferation program by acidic fibroblast growth factor (aFGF)].
    Wiedłocha A
    Postepy Hig Med Dosw; 1999; 53(2):277-89. PubMed ID: 10355293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
    Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
    Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
    Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
    Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor-2 interacts with free ribosomal protein S19.
    Soulet F; Al Saati T; Roga S; Amalric F; Bouche G
    Biochem Biophys Res Commun; 2001 Nov; 289(2):591-6. PubMed ID: 11716516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basic fibroblast growth factor sensitizes NIH 3T3 cells to apoptosis induced by cisplatin.
    Coleman AB; Momand J; Kane SE
    Mol Pharmacol; 2000 Feb; 57(2):324-33. PubMed ID: 10648642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A GR-motif functions in nuclear accumulation of the large FGF-2 isoforms and interferes with mitogenic signalling.
    Dono R; James D; Zeller R
    Oncogene; 1998 Apr; 16(16):2151-8. PubMed ID: 9572496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling.
    Kovalenko D; Yang X; Chen PY; Nadeau RJ; Zubanova O; Pigeon K; Friesel R
    Cell Signal; 2006 Nov; 18(11):1958-66. PubMed ID: 16603339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive internalization of murine MHC class I molecules.
    Mahmutefendić H; Blagojević G; Kucić N; Lucin P
    J Cell Physiol; 2007 Feb; 210(2):445-55. PubMed ID: 17044074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures.
    Mukherjee A; Dong SS; Clemens T; Alvarez J; Serra R
    Mech Dev; 2005 Apr; 122(4):557-71. PubMed ID: 15804568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.